Dr. Li is interested in translational clinical research by applying functional MRI (fMRI) technology to Alzheimer’s Disease (AD) and human drug abuse. Specifically, he and his research team are developing and validating an early, non-invasive, quantitative marker for the preclinical stage of Alzheimer’s disease (risk marker) using fMRI.